- Home
- Publications
- Publication Search
- Publication Details
Title
FOXP3 expression in esophageal squamous cell carcinoma
Authors
Keywords
-
Journal
WIENER KLINISCHE WOCHENSCHRIFT
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-10-24
DOI
10.1007/s00508-023-02291-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase II Multi-institutional Clinical Trial Result of Concurrent Cetuximab and Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
- (2022) Christine H. Chung et al. CLINICAL CANCER RESEARCH
- Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial
- (2021) Assuntina G Sacco et al. LANCET ONCOLOGY
- FOXP3 Inhibits the Metastasis of Breast Cancer by Downregulating the Expression of MTA1
- (2021) Chenlin Liu et al. Frontiers in Oncology
- Impact of EGFR-TKI Treatment on the Tumor Immune Microenvironment in EGFR Mutation–Positive Non–Small Cell Lung Cancer
- (2020) Kohsuke Isomoto et al. CLINICAL CANCER RESEARCH
- Loss of FOXP3 and TSC1 Accelerates Prostate Cancer Progression through Synergistic Transcriptional and Posttranslational Regulation of c-MYC
- (2019) Lianpin Wu et al. CANCER RESEARCH
- The addition of cetuximab to preoperative chemoradiotherapy for locally advanced esophageal squamous cell carcinoma is associated with high rate of long term survival: Mature results from a prospective phase Ib/II trial
- (2019) Baruch Brenner et al. RADIOTHERAPY AND ONCOLOGY
- Tyrosine kinase inhibitor imatinib augments tumor immunity by depleting effector regulatory T cells
- (2019) Atsushi Tanaka et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Brain regulatory T cells suppress astrogliosis and potentiate neurological recovery
- (2018) Minako Ito et al. NATURE
- Expression of Foxp3 and its prognostic significance in colorectal cancer
- (2017) Xiuwei Sun et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- Downregulation of FOXP3 inhibits cell proliferation and enhances chemosensitivity to cisplatin in human lung adenocarcinoma
- (2017) Chun Li et al. PATHOLOGY RESEARCH AND PRACTICE
- The long noncoding RNA lnc-EGFR stimulates T-regulatory cells differentiation thus promoting hepatocellular carcinoma immune evasion
- (2017) Runqiu Jiang et al. Nature Communications
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Amphiregulin Confers Regulatory T Cell Suppressive Function and Tumor Invasion via the EGFR/GSK-3β/Foxp3 Axis
- (2016) Sihua Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The prognostic value of EGFR overexpression and amplification in Esophageal squamous cell Carcinoma
- (2015) Dongxian Jiang et al. BMC CANCER
- Identification of genomic alterations in oesophageal squamous cell cancer
- (2014) Yongmei Song et al. NATURE
- FOXP3 Expression in Esophageal Cancer Cells is Associated with Poor Prognosis in Esophageal Cancer
- (2012) Gongchao Wang et al. HEPATO-GASTROENTEROLOGY
- Foxp3 overexpression decreases sensitivity to chemotherapy in mouse Lewis lung cancer cells
- (2012) CHUN LI et al. Molecular Medicine Reports
- CD4 + CD25high Regulatory T Cell Numbers and FOXP3 mRNA Expression in Patients with Advanced Esophageal Cancer Before and After Chemotherapy
- (2011) Tengyun Xu et al. CELL BIOCHEMISTRY AND BIOPHYSICS
- Expression of FOXP3 in esophageal squamous cell carcinoma relating to the clinical data
- (2009) L. Xue et al. DISEASES OF THE ESOPHAGUS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now